CeramTec acquires Dentalpoint to expand medtech expertise
The CeramTec Group has taken the next step in the transformation into a medical technology corporation and acquired the Swiss specialist for ceramic dental implants, Dentalpoint AG. With this acquisition, the medical technology group has expanded its offering as a supplier in the field of high-performance ceramics.
The CeramTec Group's high-quality, biocompatible ceramic components for joint and dental implants help patients worldwide to improve their lives.
With the acquisition of the Swiss company Dentalpoint on 4th January 2021, CeramTec is investing in the rapidly growing future market for metal-free dental prostheses and is sustainably expanding its portfolio for medical technology applications. As one of the leading suppliers in the field of metal-free, two-piece ceramic implants, Dentalpoint makes a substantial contribution to the development of implantology and has an established and innovative product platform. The transaction will create solutions in the field of ceramic dental implants, which combine the high product quality in terms of bio-compatibility and aesthetics.
"With this acquisition, we not only consistently expand our portfolio in the Medical segment, but at the same time we are expanding our access to the dental market, our product development expertise and our manufacturing capacities in a strongly growing market environment," said Dr Hadi Saleh, CEO of the CeramTec Group.
Adrian Hunn, CEO of Dentalpoint AG, added: "Through the integration into the CeramTec Group, we expect new impulses for our existing business and the expansion of our international presence. At the same time, Dentalpoint will remain a stand-alone company with the established Zeramex brand and will continue to expand."